{
  "Pharmacology": {
    "Pharmacokinetics": {
      "Analytical Methods": [2, 44, 81, 91],
      "Cytochromes": [5],
      "blood brain barrier": [153]
    },
    "Pharmacodynamics": {
      "Metabolism": [],
      "Mechanism of Action": {
        "Receptor studies": [4, 36, 57],
        "Animal models": [3, 14],
        "hippocampal neurogenesis": [29],
        "neuroimaging": [47],
        "neuroendocrine system": [47],
        "ion channels": [74],
        "serotonin transporter": [77],
        "synthesis and compounds?": [80],
        "gut microbiota": [89],
        "neurosteroids": [94],
        "astrocytic receptors": [95],
        "lipid metabolism": [107],
        "neurotrophic factors": [108],
        "Loudness Dependence of Auditory Evoked Potentials (LDAEP)": [109],
        "galanin system": [120],
        "sigma 1 receptor": [132],
        "ofaction bulbectomy": [141],
        "tryptophan metabolism": [148]
      },
      "inflammation": [23],
      "fear": [30],
      "prolonged use": [72],
      "pulmonary hypertension": [78],
      "male fertility": [97],
      "G protein": [134],
      "excitatory/inhibitory effects": [142],
      "neurotransmitter release estimation": [144],
      "animal neuroscience": [154],
      "hormonal fluctuations": [155]
    },
    "animal models of disorders": {
      "chronic unpredictable mild stress": [3],
      "forced swimming test": [14],
      "marble burying test (anxiety, ocd)": [104],
      "ofaction bulbectomy": [141]
    },
    "Pharmacogenetics": {
      "Polymorphism": [16],
      "BDNF": [27],
      "clinical pharmacogenetics": [64]
    },
    "Pharmacoepidemiology": { "Drug utilisation": [9, 68] },
    "Review": { "Review of antidepressant medications": [24] }
  },
  "Disorder/Disease": {
    "Depression": [
      3, 13, 15, 16, 18, 20, 22, 28, 32, 60, 64, 66, 73, 83, 85, 98, 105, 106,
      112, 116, 117, 121, 122, 123, 127, 128, 131, 135, 136, 138, 140, 146, 150,
      152
    ],
    "Anxiety": [30, 35, 63, 93],
    "OCD": [0],
    "PTSD": [10],
    "Panic Disorder": [31],
    "Pain": [21],
    "Inflammations": [23, 134],
    "Weight Management": [25],
    "Agitation in dementia": [26],
    "Dermatology": [39],
    "Covid": [40],
    "alcohol dependence": [41],
    "irretable bowel disease": [42],
    "premature ejaculation": [43],
    "sleep": [45],
    "eating disorders": [46],
    "bipolar disorder": [46],
    "hot flushes": [55],
    "diabetes": [56],
    "cocaine addiction": [59],
    "schizophrenia": [61],
    "epilepsy": [67],
    "autism": [69],
    "premenstrual syndromes": [70],
    "Borderline Personlaity Disorder": [87],
    "Neurological Disorders": [96],
    "seasonal affective disorder": [99],
    "fibromyalgia": [102],
    "headache": [110],
    "renal disease": [114],
    "neuropsychiatric disorders": [118],
    "addictions": [125],
    "trichotillomania": [124],
    "traumatic brain injury": [128],
    "syncope": [130],
    "cardiovascular diseases": [134],
    "oral cavity": [137],
    "multiple sclerosis": [143],
    "mutism": [147],
    "Congenital myasthenic syndromes": [149],
    "gastroprotective effects": [156]
  },
  "Safety": {
    "Serotonin syndrom": [17],
    "Sexual dysfunction": [11],
    "Suicide": [13, 28],
    "Bleeding": [33],
    "Fracture": [37],
    "Cancer": [38],
    "SSRI Toxicity": [50],
    "diabetes": [56],
    "extrapyramidal side effects": [62],
    "qt prolongation": [71],
    "prolonged use": [72],
    "hyponatremia": [82],
    "hepatic effects": [86],
    "withdrawal": [86],
    "male fertility": [97],
    "safety reviews": [100],
    "stress urinary incontinence": [111],
    "glaucoma risk": [115],
    "mania": [126],
    "Galactorrhea": [129],
    "restless legs syndrom": [145]
  },
  "Study type": {
    "Clinical Focus": [
      0, 1, 10, 11, 13, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26, 28, 31, 32, 33,
      35, 37, 38, 39, 41, 43, 45, 46, 48, 49, 50, 54, 55, 56, 60, 61, 62, 63,
      64, 66, 67, 68, 69, 71, 76, 79, 82, 83, 84, 85, 86, 87, 90, 92, 93, 96,
      98, 100, 102, 103, 105, 108, 109, 110, 112, 113, 114, 116, 117, 118, 121,
      122, 123, 124, 125, 128, 130, 131, 135, 136, 137, 138, 140, 143, 145, 146,
      147, 148, 149, 150, 152
    ],
    "Preclinical Focus": {
      "animal models of disorders": {
        "chronic unpredictable mild stress": [3],
        "forced swimming test": [14],
        "marble burying test (anxiety, ocd)": [104],
        "ofaction bulbectomy": [141]
      },
      "in vivo": [
        4, 5, 8, 21, 27, 29, 30, 34, 36, 57, 59, 72, 75, 77, 78, 89, 94, 97, 99,
        104, 119, 120, 127, 141, 142, 144, 153, 154, 156
      ],
      "in vitro": [44, 74, 81, 91]
    },
    "Environmental Focus": { "Fish": [6], "Wastewater": [7] },
    "Reviews": [
      15, 24, 35, 51, 52, 55, 60, 63, 66, 68, 69, 76, 79, 83, 84, 85, 87, 90,
      92, 93, 100, 103, 106, 110, 113, 150
    ],
    "Comparative studies": [20, 54]
  },
  "Special Populations": {
    "pregnancy": [1, 8, 92],
    "pediatrics": [13, 28, 93],
    "cardiovascular pathologies": [18],
    "post stroke": [22],
    "geriatrics": [26, 37, 48, 49, 76, 82, 83, 111],
    "diabetes": [56],
    "cancer": [106],
    "renal disease": [114],
    "hepatitis C": [135],
    "HIV": [138],
    "chronic obstructive pulmonary disease": [146]
  },
  "Drug": {
    "Fluoxetine": [12],
    "Paroxetine": [19, 36],
    "Sertraline": [51, 84],
    "Fluvoxamine": [54],
    "Citalopram": [79],
    "Escitalopram": [66, 151],
    "Venlafaxine": [60],
    "Vilazodone": [105],
    "Agomelatine": [116],
    "reboxetine": [150],
    "statins": [152]
  },
  "Other": {
    "Natural Products": [34],
    "affective effects": [53],
    "synthesis and production": [65],
    "health economics": [73, 123],
    "st johns wort": [112],
    "critical psychiatry": [133],
    "veterinary use": [139]
  }
}
